No shortage on file

REPATHA

AMGEN CANADA INC

Quick answers

Is there a shortage of REPATHA in Canada?

No. There is no current shortage of REPATHA 140MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

DIN

02446057

Strength

140MG

Dosage Form

Solution

Route

Subcutaneous

Active Ingredient

EVOLOCUMAB

See all EVOLOCUMAB products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from AMGEN CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

50MG · DIN 02459299

50MG · DIN 02459302

50MG · DIN 02459310

40MCG · DIN 02392321

500MCG · DIN 02391791

200MCG · DIN 02391775

25MCG · DIN 02392313

500MCG · DIN 02391821

500MCG · DIN 02391805

100MCG · DIN 02391759

200MCG · DIN 02391783

200MCG · DIN 02391767